Tyra Biosciences (TYRA) Equity Average (2020 - 2026)
Quarterly Equity Average fell 2.99% to $323.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $323.4 million through Mar 2026, down 2.99% year-over-year, with the annual reading at $301.2 million for FY2025, 10.03% up from the prior year.
Tyra Biosciences filings provide 7 years of Equity Average readings, the most recent being $323.4 million for Q1 2026.
- Equity Average hit $323.4 million in Q1 2026 for Tyra Biosciences, up from $269.8 million in the prior quarter.
- Across five years, Equity Average topped out at $383.0 million in Q2 2024 and bottomed at $213.2 million in Q4 2023.
- Average Equity Average over 5 years is $293.6 million, with a median of $291.3 million recorded in 2025.
- The largest annual shift saw Equity Average soared 2002.83% in 2022 before it dropped 23.5% in 2025.
- Tyra Biosciences' Equity Average stood at $262.8 million in 2022, then decreased by 18.87% to $213.2 million in 2023, then soared by 65.43% to $352.7 million in 2024, then fell by 23.5% to $269.8 million in 2025, then increased by 19.84% to $323.4 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Equity Average are $323.4 million (Q1 2026), $269.8 million (Q4 2025), and $291.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.34 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 323.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 323.38 Mn |
| Dec 31, 2025 | 269.84 Mn |
| Sep 30, 2025 | 291.33 Mn |
| Jun 30, 2025 | 312.84 Mn |
| Mar 31, 2025 | 333.34 Mn |
| Dec 31, 2024 | 352.72 Mn |
| Sep 30, 2024 | 369.17 Mn |
| Jun 30, 2024 | 382.96 Mn |
| Mar 31, 2024 | 297.07 Mn |
| Dec 31, 2023 | 213.22 Mn |
| Sep 30, 2023 | 230.37 Mn |
| Jun 30, 2023 | 243.68 Mn |
| Mar 31, 2023 | 253.31 Mn |
| Dec 31, 2022 | 262.79 Mn |
| Sep 30, 2022 | 273.30 Mn |
| Jun 30, 2022 | 285.02 Mn |
| Mar 31, 2022 | 296.46 Mn |
| Dec 31, 2021 | 305.73 Mn |
| Sep 30, 2021 | 143.53 Mn |
| Jun 30, 2021 | -20.09 Mn |
| Mar 31, 2021 | -15.58 Mn |
| Dec 31, 2020 | -11.86 Mn |